Daiichi Sankyo Expands MorphoSys Alliance To Include Antibodies For Infectious Disease

Japan's third-largest drug maker Daiichi Sankyo expanded its alliance with German biotech MorphoSys to include discovery and development of therapeutic antibodies for hospital-acquired infections. The earlier collaboration was focused solely on oncology